Towards simple, rapid point of care testing for clinically important protein biomarkers of sepsis

Lynsey Steel, Andrew C Ward, Caitlin Jeffrey, David Alcorn, Damion K Corrigan

Research output: Contribution to journalArticle

Abstract

Sepsis is characterised by a dysregulated immune response following infection with a micro-organism. Treating and managing sepsis relies on fast and accurate diagnosis followed by introduction of the correct medications and supportive measures. Biosensor measurements for sepsis typically take the route of identification of the infectious agent and/or monitoring of a clinically relevant biomarker such as lactic acid or C Reactive Protein (CRP). In this work, we have used low cost Screen Printed Electrodes (SPEs) in conjunction with antibodies for interleukin-6 and Enterotoxin A to demonstrate the possibility of measuring these two sepsis related biomarkers in 10 minutes at clinically relevant concentrations (pg/mL). The clinical utility in this approach lies in the time to result and the relative simplicity of the assay. Current biomarker testing, especially in near real time, is absent from many intensive care wards and these results demonstrate the possibility of realising such measurements. The method of sensor production employed in this study is generic and therefore can be applied to a panel of similar sepsis biomarkers on a wide variety of electrode substrates. These results demonstrate a clear direction towards a simple multi-marker assay for sepsis which can assist with diagnosis, triaging and clinical management of the condition as it progresses and recedes.
LanguageEnglish
Pages1-8
JournalSCIOL Biotechnology
Volume1
Issue number1
Publication statusPublished - 15 Dec 2017

Fingerprint

Biomarkers
Sepsis
Proteins
Testing
Assays
Electrodes
Lactic acid
Biosensors
Antibodies
Enterotoxins
Biosensing Techniques
Critical Care
C-Reactive Protein
Point-of-Care Testing
Monitoring
Lactic Acid
Interleukin-6
Sensors
Substrates
Costs

Keywords

  • sepsis
  • immune responses
  • protein biomarkers

Cite this

@article{b045e29267844a1ba46829b13392fc6e,
title = "Towards simple, rapid point of care testing for clinically important protein biomarkers of sepsis",
abstract = "Sepsis is characterised by a dysregulated immune response following infection with a micro-organism. Treating and managing sepsis relies on fast and accurate diagnosis followed by introduction of the correct medications and supportive measures. Biosensor measurements for sepsis typically take the route of identification of the infectious agent and/or monitoring of a clinically relevant biomarker such as lactic acid or C Reactive Protein (CRP). In this work, we have used low cost Screen Printed Electrodes (SPEs) in conjunction with antibodies for interleukin-6 and Enterotoxin A to demonstrate the possibility of measuring these two sepsis related biomarkers in 10 minutes at clinically relevant concentrations (pg/mL). The clinical utility in this approach lies in the time to result and the relative simplicity of the assay. Current biomarker testing, especially in near real time, is absent from many intensive care wards and these results demonstrate the possibility of realising such measurements. The method of sensor production employed in this study is generic and therefore can be applied to a panel of similar sepsis biomarkers on a wide variety of electrode substrates. These results demonstrate a clear direction towards a simple multi-marker assay for sepsis which can assist with diagnosis, triaging and clinical management of the condition as it progresses and recedes.",
keywords = "sepsis, immune responses, protein biomarkers",
author = "Lynsey Steel and Ward, {Andrew C} and Caitlin Jeffrey and David Alcorn and Corrigan, {Damion K}",
year = "2017",
month = "12",
day = "15",
language = "English",
volume = "1",
pages = "1--8",
journal = "SCIOL Biotechnology",
number = "1",

}

Towards simple, rapid point of care testing for clinically important protein biomarkers of sepsis. / Steel, Lynsey; Ward, Andrew C; Jeffrey, Caitlin; Alcorn, David; Corrigan, Damion K.

In: SCIOL Biotechnology, Vol. 1, No. 1, 15.12.2017, p. 1-8.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Towards simple, rapid point of care testing for clinically important protein biomarkers of sepsis

AU - Steel, Lynsey

AU - Ward, Andrew C

AU - Jeffrey, Caitlin

AU - Alcorn, David

AU - Corrigan, Damion K

PY - 2017/12/15

Y1 - 2017/12/15

N2 - Sepsis is characterised by a dysregulated immune response following infection with a micro-organism. Treating and managing sepsis relies on fast and accurate diagnosis followed by introduction of the correct medications and supportive measures. Biosensor measurements for sepsis typically take the route of identification of the infectious agent and/or monitoring of a clinically relevant biomarker such as lactic acid or C Reactive Protein (CRP). In this work, we have used low cost Screen Printed Electrodes (SPEs) in conjunction with antibodies for interleukin-6 and Enterotoxin A to demonstrate the possibility of measuring these two sepsis related biomarkers in 10 minutes at clinically relevant concentrations (pg/mL). The clinical utility in this approach lies in the time to result and the relative simplicity of the assay. Current biomarker testing, especially in near real time, is absent from many intensive care wards and these results demonstrate the possibility of realising such measurements. The method of sensor production employed in this study is generic and therefore can be applied to a panel of similar sepsis biomarkers on a wide variety of electrode substrates. These results demonstrate a clear direction towards a simple multi-marker assay for sepsis which can assist with diagnosis, triaging and clinical management of the condition as it progresses and recedes.

AB - Sepsis is characterised by a dysregulated immune response following infection with a micro-organism. Treating and managing sepsis relies on fast and accurate diagnosis followed by introduction of the correct medications and supportive measures. Biosensor measurements for sepsis typically take the route of identification of the infectious agent and/or monitoring of a clinically relevant biomarker such as lactic acid or C Reactive Protein (CRP). In this work, we have used low cost Screen Printed Electrodes (SPEs) in conjunction with antibodies for interleukin-6 and Enterotoxin A to demonstrate the possibility of measuring these two sepsis related biomarkers in 10 minutes at clinically relevant concentrations (pg/mL). The clinical utility in this approach lies in the time to result and the relative simplicity of the assay. Current biomarker testing, especially in near real time, is absent from many intensive care wards and these results demonstrate the possibility of realising such measurements. The method of sensor production employed in this study is generic and therefore can be applied to a panel of similar sepsis biomarkers on a wide variety of electrode substrates. These results demonstrate a clear direction towards a simple multi-marker assay for sepsis which can assist with diagnosis, triaging and clinical management of the condition as it progresses and recedes.

KW - sepsis

KW - immune responses

KW - protein biomarkers

UR - https://sciol.org/articles/biotechnology/fulltext.php?aid=sbt-1-001

M3 - Article

VL - 1

SP - 1

EP - 8

JO - SCIOL Biotechnology

T2 - SCIOL Biotechnology

JF - SCIOL Biotechnology

IS - 1

ER -